Mankind Pharma - Results 2025

1) Mankind Pharma has declared results for march 25 2) Q4FY25 Financial Highlights: 3) Revenue from Operations at Rs 3,079 crore, up by 27% YoY Domestic revenue at Rs 2,544 crore, up 18% YoY, Exports at Rs 535 crore, up 100% YoY Adjusted EBITDA margin of 23.1% down by 120 bps YoY and PAT margin of 13.9% Diluted EPS of Rs 10.3 down by 12.5% YoY (FV Re.1) 4)FY25 Financial Highlights: Revenue from Operations at Rs 12,207 crore, up by 19% YoY Domestic revenue at Rs 10,675 crore, up 13% YoY, Exports at Rs 1,532 crore, up 88% YoY Adjusted EBITDA margin of 25.9% up by 130 bps YoY and PAT margin of 16.4% Diluted EPS of Rs 49.1, up by 3% YoY (FV Re.1) 5) Results not so good. 6) This is not a buy/sell call 7) This is only for information. Thank you, Technofunda24